Try our beta test site
37 studies found for:    Prevention of mother-to-child transmission OR PMTCT OR MTCT OR perinatal transmission OR vertical transmission | Open Studies | HIV
Show Display Options
Rank Status Study
21 Recruiting Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
Conditions: HIV/AIDS;   Antiretroviral Therapy;   Pregnancy Outcomes;   HIV-exposed Infants
Intervention: Other: Continuous quality improvement
22 Recruiting Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care
Conditions: Pregnancy;   HIV
Interventions: Other: Quality Improvement;   Other: Baseline data collection (active comparator)
23 Recruiting Evaluating the Safety and Pharmacokinetics of VRC01, a Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1-Exposed Infants
Condition: HIV Infections
Intervention: Biological: VRC01
24 Recruiting Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Condition: HIV/AIDS
Intervention:
25 Recruiting Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women
Conditions: HIV Infections;   Depression
Interventions: Behavioral: BEST-maCARE;   Behavioral: Attention Control Condition
26 Recruiting Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438);   Biological: Bivalent Subtype C gp120/MF59;   Biological: Placebo
27 Not yet recruiting Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Maraviroc
28 Not yet recruiting A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa
Condition: HIV-1
Interventions: Biological: Ad26.Mos4.HIV;   Biological: Clade C gp140;   Biological: Placebo
29 Recruiting IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
Condition: HIV Infection
Intervention: Drug: Intensive ART regimen
30 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
31 Recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
32 Recruiting Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) film-coated tablets;   Drug: DTG granules for suspension;   Drug: DTG dispersible tablets
33 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
34 Not yet recruiting Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
Condition: HIV Infections
Interventions: Drug: N(t)RTIs;   Drug: Dolutegravir;   Drug: Darunavir;   Drug: Ritonavir
35 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
36 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
37 Recruiting Sustainable East Africa Research in Community Health
Conditions: HIV;   Tuberculosis;   Hypertension;   Diabetes;   Maternal Child Health;   Cost Effectiveness
Interventions: Other: Universal ART in a streamlined care model;   Other: Annual Community Health Campaigns;   Other: Targeted PrEP, Targeted testing, and Targeted care interventions;   Other: Baseline community-based HIV and multi-disease testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.